Characterization of epidermal growth factor receptor in normal and neoplastic human endometrium.
Growth factors, including epidermal growth factor (EGF), have been implicated in the growth of several types of cancer. This study compares EGF receptors in normal and neoplastic endometrium. Membrane fractions were isolated from surgical specimens. Radioreceptor assays demonstrated the presence of receptors with a dissociation constant of 0.64 nmol/l in normal endometrium. Affinity cross-linking revealed receptor molecular weight of 150 to 170 kiloDaltons (KD). A survey of samples (n = 37) revealed progressive decrease of EGF receptors in cancers of increasing grade: Grade 1-2 adenocarcinoma decreased 34% from control (n = 6, P less than 0.01), whereas Grade 3 adenocarcinoma decreased 90% (n = 7, P less than 0.01) and sarcoma decreased by 72% (n = 3, P less than 0.01). The dissociation constant and molecular weight of the receptor in neoplastic endometrium did not differ significantly from normal. The inverse relationship with grade suggests receptor alteration or down regulation by hormones and/or growth factors.
Reynolds
R K
RK
Department of Obstetrics and Gynecology, University of Michigan Hospitals, Ann Arbor.
Talavera
F
F
Roberts
J A
JA
Hopkins
M P
MP
Menon
K M
KM
D000230:Adenocarcinoma / Q000378:metabolism / Q000648:ultrastructure*; D000818:Animals; D004717:Endometrium / Q000378:metabolism / Q000648:ultrastructure*; D004815:Epidermal Growth Factor / Q000378:metabolism; D066246:ErbB Receptors / Q000737:chemistry / Q000378:metabolism*; D005260:Female; D006801:Humans; D007700:Kinetics; D051379:Mice; D008970:Molecular Weight; D014594:Uterine Neoplasms / Q000378:metabolism / Q000648:ultrastructure*
D004815:Epidermal Growth Factor; D066246:ErbB Receptors